Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Canna Law Blog

OCTOBER 27, 2020

It’s going to take a couple of years for the first of these to roll out, and we should have even more scientific research and public acceptance for the medical applications of psilocybin by then. The Oregon program will not square with federal laws.

DEA 83

DEA Decriminalization Research and Development Programs 83

Cannabis Law Report

AUGUST 18, 2022

One year after the United States Department of Agriculture (USDA) issued its final rules on hemp, various states enacted their own regulatory programs. With that research, they created elaborate matrices to compare each mandate. We developed the National Hemp Testing Panel because comprehensive testing is key to the industry’s future.

Compliance 52

Compliance Compliance Hemp Research and Development 52

SpeedWeed

AUGUST 11, 2021

According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community. Veterans are demanding objective cannabis drug development research, and the state of Michigan is fulfilling our collective obligation to our beloved Veteran community.”.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential.

CBD 99

CBD DEA Research and Development Hemp 99

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 21, 2022

MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices. The full statement. Nair, Ph.D., lead author and MAPS PBC Head of Chemistry, Manufacturing, and Controls. Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. Another for of ‘prescribed’ cannabis is Marinol , which is synthetic THC, developed in the 80’s and used for such conditions as Cancer and AIDS. Cannabis is a schedule 1 substance.

DEA 52

DEA Patients Conditions Cannabis 52

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. The Next Move Is On The DEA. FDA Grants Approval of Epidiolex.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JULY 28, 2022

An Examination of the USDA Hemp Production Program. Testimonies During The House Agriculture Subcommittee On Biotechnology, Horticulture, And Research Addressed FDA Inaction on CBD and Intoxicating Hemp Derivatives. Washington D.C. Today, U.S. That reluctance, in turn, has dampened industry demand for harvested hemp material.”. “In

Agriculture 52

Agriculture Hemp CBD Research and Development 52

SMPL

AUGUST 14, 2019

Finally, the resolution recommends that Congress pass legislation to “encourage scientific research into the efficacy, dose, routes of administration, or side effects of commonly used and commercially available cannabis products in the United States.”. The final part of the resolution discusses the need to support research into cannabis.

Policy 40

Policy Research and Development Marijuana DEA 40

Veriheal

SEPTEMBER 9, 2021

” This fee — which is designed to support social equity programs — is required to convert up to three medical cannabis dispensaries into dual medical-recreational facilities. Contingent on reenactments in 2022, specific license caps will be implemented for Virginia’s adult-use cannabis program. Retail stores: 400.

Legalization 109

Legalization Recreational Business Retail 109

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

JULY 28, 2021

To a large extent legalization of adult-use cannabis, including New York’s passage of the Marijuana Regulation and Taxation Act of 2021 (MRTA), has eclipsed other developments in the cannabis sector over the past year. 5940), which allows hemp to be cultivated for research (as opposed to commercial) purposes. ” See 7 U.S.C.

THC 105

THC Hemp CBD Cannabinoids 105

The Cannigma

MAY 1, 2023

Named because it is the result of the joining two different chemical types – a ketone and an amine, ketamine was developed in 1962 as an alternative dissociative anesthetic drug to the potently hallucinogenic phencyclidine, known more commonly as PCP. It was becoming clear that another class of anesthetics was needed.

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). if the plant is moved to Schedule III.

Research and Development 116

Research and Development DEA Marijuana Pharmaceutical 116

Otherside Farms

AUGUST 4, 2020

Concrete extraction technicians, researchers, marijuana cultivators, marketers, marijuana processors, cannabis branding, and developers will all have a place in the industry. There are a number of ways that your skills can be used to develop a business. Research Your Competitors.

Business 52

Business Banking Dispensary Research and Development 52

Cannabis Law Report

APRIL 14, 2022

Although research is still underway, the effects of both short- and long-term exposure to pesticides by consuming (i.e., Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. pursuant to Drug Enforcement Agency (DEA) or state-level programs). million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52

SpeedWeed

MARCH 5, 2021

Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition.

Business 52

Business Policy Clinical Trials Research and Development 52

Canna Law Blog

MAY 24, 2024

The Drug Enforcement Administration (DEA) published its Notice of Proposed Rulemaking (“NOPR”) last week to much fanfare. In my very quick analysis after the rule dropped, I flagged DEA’s statement that it may develop “marijuana-specific controls” in conjunction with rescheduling. Marijuana-specific controls in schedule III?

DEA 108

DEA Marijuana Research and Development Policy 108

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 74

DEA Research and Development Cultivation Supply Chain 74

Veriheal

JUNE 29, 2021

Did we ever stop to think that if we could legally utilize the plants in the first place that perhaps we wouldn’t develop terminal illnesses at such a high rate? The FDA refers to this program as the expanded access program on their website. Introducing the Right to Try Act. Sunil Aggarwal was also named in the lawsuit.

Therapy 55

Therapy DEA Patients Clinical Trials 55

The Joint Blog

SEPTEMBER 19, 2019

It’s Russian roulette,” said James Neal-Kababick, director of Flora Research Laboratories, which tested the products. Vaping, in general, has come under increased scrutiny in recent weeks because hundreds of users have developed mysterious lung illnesses, and several have died. Vapes are not covered.

Vaping 44

Vaping Oil CBD Marijuana 44

Cannabis Law Report

JULY 1, 2021

On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Research suggests that about one in five people will have an increase in paranoia as a result of the delta-9 THC after consuming cannabis. And that was just the beginning. The Risk of Delta-8 Products with High Delta-9 For Anxiety and Depression.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 13, 2022

North American Industry Leader in Psychedelic Therapy and Research. Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Watch Video: The Press Release. NEWS PROVIDED BY. Numinus Wellness Inc. .

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MAY 1, 2019

29 The Department of Justice alleged that Google had “allow[ed] online Canadian pharmacies to place advertisements through its AdWords program targeting consumers in the United States” and that Google specifically assisted the pharmacies in “optimizing their AdWords advertisements, and improving the effectiveness of their websites.”

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. This process should also ensure appropriate funding allocated for this research.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Project CBD

AUGUST 23, 2023

23 Yet this conversion is occurring without regulatory oversight to ensure process standardization, product specification, and accurate third-party testing, all of which are mandated in state-licensed cannabis programs. 22 These non-natural THC-like isomers are difficult to measure and almost impossible to remove from the end product.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock). However, the first researcher that identified and isolated THC was the American Roger Adams in the early 1940’s. Who discovered THC?

THC 98

THC Research and Development Cannabinoids CBD 98

SpeedWeed

FEBRUARY 24, 2021

Noncompliant hemp used to require its disposal or remediation be conducted by a government official from an agency like the DEA. Hemp must be tested at DEA-registered laboratories, as previous rules state. 3% an extreme limit for hemp genetics and cultivators, positing that the rule will limit innovation and plant research.

Hemp 52

Hemp DEA Research and Development Compliance 52

The Cannigma

FEBRUARY 16, 2022

To hear more about Steven’s research, what he hopes it will lead to, his predictions for the future of cannabis, how he is helping those most harmed by the war on drugs, and how you can help too, tune in today! SP: Yeah, so I guess right now, with my research, I am actually looking to create a catalog of trichomes. SP: Say that again.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73